Brett Arends’s ROI: Only ‘greedy’ drug companies will cure Alzheimer’s


Why should people invest in companies making lifesaving drugs when they can make more in booze and cigarettes?

StockWatch: AMD’s stock has been left behind, but not for long — here’s why

Previous article

Outside the Box: A more accurate inflation indicator is painting a bleaker picture for rising prices

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News